Erythrocyte invasion in malaria: molecular mechanism to precision therapeutics

Malaria parasites punch their way into red blood cells to survive, and this project will map the molecular machinery they use to do it. This matters because the parasite’s ability to invade red blood cells is the central event that causes disease symptoms, fuels parasite growth, and enables transmission to mosquitoes. Blocking that invasion would stop malaria in its tracks. The research focuses on a protein complex called PfRCR—made of PfRH5, PfCyRPA, and PfRIPR—which is essential for the invasion process. Scientists know the complex is critical, but they do not fully understand how it works at the molecular level, nor how the most potent human antibodies neutralise it. If this research succeeds, it will provide the structural blueprints needed to design better vaccines and therapeutic antibodies against malaria. The work is a mix of fundamental science—determining protein structures and invasion mechanisms—and applied design. By revealing how antibodies block invasion, the findings could guide the engineering of next-generation malaria therapeutics that are more effective and longer-lasting. This is not a cure ready for the clinic tomorrow, but a deep molecular understanding that could underpin future treatments.